Genomic Valley Biotech quarterly results and financials

Genomic Valley Biotech (BSE 539206)₹50.13−9.72%(9 Nov 2026 close)Biotechnology

Key facts

In the Mar 2026 quarter (standalone), Genomic Valley Biotech reported sales of ₹0.03 Cr, down 88.0% from Mar 2025, and net profit of −₹0.02 Cr. For the year to Mar 2026, sales were ₹0.26 Cr and net profit ₹0.04 Cr.

Sales (Mar 2026): ₹0.03 Cr
Net profit (Mar 2026): −₹0.02 Cr
Sales (FY Mar 2026): ₹0.26 Cr
Net profit (FY Mar 2026): ₹0.04 Cr
EPS (Mar 2026): ₹−0.02
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Genomic Valley Biotech quarterly results

₹ crore unless stated; each column is a quarter.

Genomic Valley Biotech Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	0.05	0.06	0.03	0.00	0.15	0.20	0.21	0.25	0.08	0.08	0.04	0.03
Expenses	0.02	0.04	0.01	0.03	0.02	0.06	0.05	0.25	0.05	0.08	0.03	0.03
Operating Profit	0.02	0.01	0.01	−0.03	0.12	0.13	0.15	0.00	0.02	0.00	0.00	0.00
OPM %	50.0%	28.5%	50.0%	—	81.2%	66.7%	72.7%	0.0%	33.3%	0.0%	20.0%	0.0%
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.04	0.03	0.03	−0.05	0.14	0.16	0.17	0.00	0.04	0.00	0.02	0.00
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	0.0%	—	0.0%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.04	0.03	0.03	−0.05	0.14	0.16	0.17	−0.09	0.03	0.00	0.02	−0.02
EPS (Rs)	0.09	0.08	0.06	−0.12	0.44	0.48	0.51	−0.27	0.06	0.00	0.02	−0.02

Genomic Valley Biotech profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Genomic Valley Biotech Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.10	0.43	0.58	0.98	0.84	0.20	0.06	2.71	0.16	0.83	0.26	0.23
Expenses	0.53	0.47	0.48	0.56	0.29	0.33	0.44	1.83	0.14	0.39	0.22	0.19
Operating Profit	−0.42	−0.03	0.09	0.41	0.54	−0.12	−0.37	0.87	0.01	0.43	0.03	0.02
OPM %	−390.9%	−9.1%	16.9%	42.4%	64.7%	−61.9%	−542.9%	32.3%	11.8%	52.4%	14.8%	8.7%
Other Income	0.15	0.00	0.02	0.00	0.00	0.00	0.49	−0.21	0.00	0.00	0.00	0.00
Interest	0.01	0.00	0.00	0.00	0.17	0.17	0.03	0.00	0.00	0.00	0.00	0.00
Depreciation	0.04	0.03	0.07	0.18	0.17	0.18	0.07	0.00	0.00	0.00	0.00	0.00
Profit before tax	−0.35	−0.08	0.06	0.25	0.21	−0.51	0.00	0.66	0.03	0.45	0.05	0.06
Tax %	−2.9%	0.0%	40.1%	0.0%	−39.9%	12.0%	—	0.0%	0.0%	20.5%	25.1%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	−0.34	−0.08	0.04	0.24	0.30	−0.57	−0.02	0.66	0.03	0.37	0.04	0.03
EPS (Rs)	−1.07	−0.24	0.09	0.74	0.96	−1.84	−0.04	2.12	0.06	1.19	0.09	0.06
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Genomic Valley Biotech balance sheet

₹ crore, at each year end.

Genomic Valley Biotech Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.05	3.05	3.04	3.04	3.04	3.04	3.04	3.05	3.04	3.04	3.04	3.04
Reserves	1.85	1.52	1.45	1.48	1.72	2.00	1.44	−0.19	0.48	0.50	0.85	0.87
Borrowings	0.75	0.75	0.76	0.74	1.49	1.49	1.54	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.80	0.73	0.77	1.41	0.92	1.47	1.59	0.93	0.89	0.79	0.46	0.32
Total Liabilities	6.45	6.05	6.02	6.67	7.17	8.00	7.61	3.79	4.41	4.33	4.35	4.23
Fixed Assets	3.16	3.19	3.64	4.13	4.32	4.48	5.87	1.76	0.00	0.00	0.02	0.00
CWIP	0.00	0.00	0.00	0.37	0.48	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Investments	0.56	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.00	0.00
Other Assets	2.73	2.74	2.38	2.17	2.37	3.04	1.26	2.03	4.41	4.30	4.33	4.23
Inventories	0.00	0.00	0.06	0.02	0.11	0.11	0.00	0.00	0.00	0.00	0.27	0.27
Trade receivables	0.00	0.00	0.00	0.03	0.07	0.11	0.07	0.00	2.23	2.54	2.22	2.33
Cash & equivalents	0.16	0.00	0.04	0.00	0.07	0.03	0.00	0.00	0.03	0.00	0.04	0.02
Total Assets	6.45	6.05	6.02	6.67	7.17	8.00	7.61	3.79	4.41	4.33	4.35	4.23

Genomic Valley Biotech cash flow

₹ crore, for each year.

Genomic Valley Biotech Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.10	−0.70	0.36	0.88	−1.05	0.45	1.49	−2.14	−0.79	−0.03	0.04	−0.03
Cash from investing activity	−0.66	0.54	−0.32	−0.92	0.38	−0.48	−1.59	3.68	1.53	−0.03	0.02	0.00
Cash from financing activity	0.00	0.00	0.00	0.00	0.72	0.00	0.06	−1.54	−0.69	0.00	0.00	0.00
Net cash flow	−0.55	−0.15	0.03	−0.03	0.05	−0.03	−0.02	0.00	0.03	−0.03	0.03	−0.01
Capex	0.13	0.07	0.49	0.93	0.00	0.47	1.57	0.00	0.00	0.00	0.00	0.00
Free cash flow	−0.06	−0.78	−0.16	−0.08	−0.69	−0.05	−0.11	3.23	0.71	−0.03	0.03	−0.03
CFO / OP %	−225.0%	160.0%	−875.0%	870.0%	−248.0%	80.0%	−1,138.0%	561.0%	−89.0%	−100.0%	27.0%	−25.0%

Genomic Valley Biotech ratios

Working-capital days and returns, by year.

Genomic Valley Biotech Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	0	0	0	12	22	43	104	0	298	5,432	960	3,136
Inventory days	0	0	—	—	—	—	0	—	0	—	487	—
Days payable	—	—	—	—	—	—	—	—	—	—	17	—
Cash conversion cycle	0	0	0	13	23	44	105	0	299	5,433	1,431	3,137
Working capital days	−8,882	−1,659	−514	−804	55	−176	−1,251	4,849	221	4,530	917	3,177
ROCE %	0.4%	−5.8%	−0.6%	0.6%	4.2%	6.0%	−5.1%	−8.5%	28.5%	0.6%	11.9%	1.0%

Genomic Valley Biotech: frequently asked questions

What are the latest quarterly results of Genomic Valley Biotech?

For the Mar 2026 quarter, Genomic Valley Biotech reported sales of ₹0.03 Cr, down 88.0% year on year and net profit of −₹0.02 Cr. The operating margin was 0.0%.

What is the annual revenue of Genomic Valley Biotech?

Genomic Valley Biotech's sales for the year to Mar 2026 were ₹0.26 Cr; over the last twelve months they were ₹0.23 Cr.

What is the net profit of Genomic Valley Biotech?

Net profit for the year to Mar 2026 was ₹0.04 Cr, and ₹0.03 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.06.

How much debt does Genomic Valley Biotech have?

Genomic Valley Biotech reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.02 Cr.

What is the free cash flow of Genomic Valley Biotech?

Cash from operations was −₹0.03 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.03 Cr.

Loading…